CA Stock MarketDetailed Quotes
COT.H Cotinga Pharmaceuticals Inc
- 0.000
- 0.0000.00%
15min DelayMarket Closed Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio21.99MShares0.00052wk Low-0.11EPS TTM0Float Cap0.000Historical High0.00P/E (Static)21.99MShs Float0.000Historical Low-0.12EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Cotinga Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jan 31, 2020 | (Q2)Oct 31, 2019 | (Q1)Jul 31, 2019 | (FY)Apr 30, 2019 | (Q4)Apr 30, 2019 | (Q3)Jan 31, 2019 | (Q2)Oct 31, 2018 | (Q1)Jul 31, 2018 | (FY)Apr 30, 2018 | (Q4)Apr 30, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -526.42%-72.46K | 76.79%-120.54K | 78.76%-233.68K | 57.46%-1.69M | 79.66%-89.46K | 101.89%16.99K | 67.28%-519.32K | -4.69%-1.1M | 8.56%-3.98M | 61.62%-439.83K |
| Net income from continuing operations | -90.72%-533.67K | -8.51%-536.7K | 46.33%-526.81K | 44.73%-2.7M | 40.39%-941.26K | 78.11%-279.81K | 72.22%-494.63K | -305.61%-981.59K | 21.40%-4.88M | 17.20%-1.58M |
| Operating gains losses | --0 | 99.94%-20 | -100.12%-17 | 113.49%176.45K | 767.52%195.83K | 100.95%1.01K | ---34.28K | --13.89K | -118.46%-1.31M | -123.17%-29.34K |
| Depreciation and amortization | -25.02%20.48K | -25.30%20.59K | -32.73%21.13K | -48.45%112.79K | -49.28%26.52K | -49.10%27.31K | -50.89%27.56K | -44.66%31.41K | -12.29%218.8K | -37.40%52.28K |
| Remuneration paid in stock | --0 | --0 | -99.37%641 | -74.92%190.34K | -100.25%-585 | -85.99%20.77K | -52.52%68.8K | -55.67%101.36K | -26.60%758.88K | -32.15%237.11K |
| Deferred tax | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 69.57%-43.89K | 8.47%-25.89K |
| Other non cashItems | --42.79K | --42.59K | --28.65K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 60.64%397.94K | 506.81%353K | 191.52%242.73K | -58.83%525.76K | -31.00%630.04K | -10.89%247.72K | 21.15%-86.77K | -235.34%-265.22K | 11.15%1.28M | 2,827.22%913.12K |
| -Change in receivables | -103.29%-793 | -142.19%-2.4K | -73.60%4.38K | 242.07%61.01K | --14.65K | --24.08K | -78.20%5.69K | 141.10%16.59K | 213.91%17.84K | ---- |
| -Change in prepaid assets | 22.87%25.7K | 30.19%33.75K | -31.03%37.18K | -20.67%109.84K | --9.09K | --20.92K | -63.38%25.92K | -33.12%53.91K | 531.71%138.46K | ---- |
| -Change in payables and accrued expense | 84.02%373.03K | 371.71%321.66K | 159.92%201.17K | -68.33%354.91K | --606.3K | --202.71K | 42.79%-118.38K | -315.58%-335.72K | -1.92%1.12M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -526.42%-72.46K | 76.79%-120.54K | 78.76%-233.68K | 57.46%-1.69M | 79.66%-89.46K | 101.89%16.99K | 67.28%-519.32K | -4.69%-1.1M | 8.56%-3.98M | 60.48%-439.83K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | -101.05%-12.7K | 0 | 85.37%-1.4K | -17.34%-8.51K | -100.24%-2.79K | 13.21%1.21M | -95.53%45.05K |
| Net PPE purchase and sale | --0 | --0 | --0 | 106.57%150 | --0 | --0 | --0 | 103.77%150 | 87.90%-2.28K | --0 |
| Net intangibles purchas and sale | --0 | --0 | --0 | 83.90%-12.85K | --0 | 85.37%-1.4K | 4.94%-8.51K | 93.05%-2.94K | 61.06%-79.83K | 80.83%-18.97K |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -0.06%1.29M | -94.24%64.02K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | -101.05%-12.7K | --0 | 85.37%-1.4K | -17.34%-8.51K | -100.24%-2.79K | 13.21%1.21M | -95.53%45.05K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 85K | 110K | -96.85%53.18K | -9.70%1.89M | 237.04%199.97K | 0 | 0 | 44,335.50%1.69M | 14.64%2.09M | 143.39%59.33K |
| Net issuance payments of debt | --85K | --110K | --100K | --199.97K | --199.97K | --0 | --0 | --0 | --0 | ---- |
| Net common stock issuance | --0 | --0 | --0 | -2.71%2.01M | --0 | --0 | --0 | --2.01M | 14.64%2.07M | 111.25%5.24K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -113.90%-3.8K | ---- |
| Net other financing activities | --0 | --0 | 85.44%-46.82K | -1,200.25%-321.61K | --0 | --0 | --0 | ---321.61K | 1,170.34%29.23K | 149.59%57.89K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --85K | --110K | -96.85%53.18K | -9.70%1.89M | 237.04%199.97K | --0 | --0 | 44,335.50%1.69M | 14.64%2.09M | 143.39%59.33K |
| Net cash flow | ||||||||||
| Beginning cash position | -65.92%33.57K | -92.96%44.11K | 451.45%224.61K | -94.32%40.73K | -69.67%114.1K | -91.69%98.51K | -26.44%626.34K | -94.32%40.73K | -66.49%717.68K | -60.82%376.18K |
| Current changes in cash | -19.59%12.54K | 98.00%-10.54K | -130.82%-180.5K | 127.16%183.88K | 132.94%110.51K | 101.93%15.59K | -257.71%-527.83K | 337.77%585.61K | 53.55%-676.95K | -38.00%-335.45K |
| End cash Position | -59.59%46.11K | -65.92%33.57K | -92.96%44.11K | 451.45%224.61K | 451.45%224.61K | -69.67%114.1K | -91.69%98.51K | -26.44%626.34K | -94.32%40.73K | -94.32%40.73K |
| Free cash from | -564.74%-72.46K | 77.16%-120.54K | 78.82%-233.68K | 58.01%-1.7M | 80.50%-89.46K | 101.71%15.59K | 66.89%-527.83K | -0.54%-1.1M | 11.24%-4.06M | 62.34%-458.8K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data